S. Snapinn, M. Chen, Q. Jiang, and T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
J. Cook, P. McCulloch, J. Blazeby, D. Beard, D. Marinac-Dabic, and A. Sedrakyan. BMJ (Clinical research ed.), (January 2013)GR: G1002292/Medical Research Council/United Kingdom; GR: HHSF22321110172C/PHS HHS/United States; JID: 8900488; OID: NLM: PMC3685513; epublish;.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
N. Hawkins, R. Sanson-Fisher, A. Shakeshaft, C. D'Este, and L. Green. American journal of preventive medicine, 33 (2):
162-8(August 2007)4640<m:linebreak></m:linebreak>LR: 20071115; JID: 8704773; RF: 73; 2006/05/16 received; 2007/02/23 revised; 2007/03/31 accepted; ppublish;<m:linebreak></m:linebreak>Tipus d'estudis.
H. Bucher, G. Guyatt, L. Griffith, and S. Walter. Journal of clinical epidemiology, 50 (6):
683-91(June 1997)2443<m:linebreak></m:linebreak>Metaanàlisi.